COVID-19: Okayama University Hospital, ivermectin clinical trial started: for mildly ill patients
-Expected as a corona remedy-
Okayama University Hospital:
The antiparasitic drug “ivermectin” is expected as a therapeutic drug for the new coronavirus.
We are promoting clinical trials (clinical trials) of the antiparasitic drug “ivermectin”.
It will be carried out on 5 positive individuals by the end of October to confirm the therapeutic effect.
Send the results to Kitasato University Hospital (Sagamihara City), which requested the clinical trial.
Ivermectin clinical trial subjects:
The subjects of the clinical trial are adults weighing 40 kg or more who tested positive for the corona PCR test.
Asymptomatic or mildly infected
Being treated at home or at accommodation,
Etc. are the conditions.
Confirmation of symptoms on the 15th day after taking the drug:
The collaborators will be hospitalized at Okayama University Hospital for at least 7 days.
Take ivermectin or placebo on the first day,
After receiving a PCR test and seeing a doctor once every two days
The patient will be discharged if 10 days have passed since the onset.
After that, go to the hospital and check the symptoms on the 15th day after taking the medicine.
Kitasato University Hospital:
Kitasato University Hospital and others have been conducting clinical trials of ivermectin since September last year.
Okayama University Hospital received a request for cooperation in June.
Sanyo Shimbun Digital ｜ San Digi
https://www.sanyonews.jp/article/1177186
[Request for participation in clinical trials]
Ivermectin therapy for new coronavirus infections
Okayama University Hospital
Ivermectin therapy for new coronavirus infection has started.
Clinical trial subjects
Those who have confirmed the diagnosis of new coronavirus infection in Okayama prefecture.
Okayama University Graduate School of Medical, Dental and Pharmaceutical Sciences